Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Sareum Holdings

    MCap

    GBP41m

    Last close

    GBP0.37

    ▲ 0.00 (0.00%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    OpGen

    MCap

    USD58m

    Last close

    USD4.60

    ▲ 0.59 (14.60%)

  • Sectors

    Sectors

    View All Sectors
  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Sparks commentary - Oryzon Genomics

Healthcare

Sparks - Oryzon Genomics

More on this equity
testalize-me-0jE8ynV4mis-unsplash
Oryzon (BME: ORY) doses first patient in new AML trial
Published by Arron Aatkar, PhD

Oryzon Genomics has announced the first patient dosing in its Phase I trial, sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health. This study (NCT06514261) is assessing Oryzon’s potent and selective LSD1 inhibitor, iadademstat, in combination with venetoclax and azacitidine (standard of care) in newly diagnosed acute myeloid leukaemia (AML) patients. The trial aims to enrol 45 patients and is being conducted under a Cooperative Research and Development Agreement that Oryzon has in place with the NCI.

Next Sparks Commentary in this sector >

Latest

Real Estate | Comment

Intershop Holding (SIX: ISN) – Interim results

Healthcare | Comment

Starpharma (ASX: SPL) – Partnerships and funding strengthen the runway to the clinic

Industrials | Comment

Metlen Energy & Metals (LSE: MTLN; ATHEX: MYTIL) – Proposed demerger of concessions and PPP activities

Healthcare | Comment

Mendus (OMX: IMMU) – CML momentum builds (Q226 results)

Healthcare | Comment

Herantis Pharma (HEL: HRTIS) – Phase II preparations take centre stage (H126 results)
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.